| (Values in U.S. Thousands) | Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 |
| Sales | 140 | 320 | 390 | 250 | 230 |
| Sales Growth | -56.25% | -17.95% | +56.00% | +8.70% | +53.33% |
| Net Income | -2,150 | -1,410 | -2,480 | -7,680 | -3,080 |
| Net Income Growth | -52.48% | +43.15% | +67.71% | -149.35% | +66.12% |
Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Comera Life Sciences Inc. is involved in developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience. Comera Life Sciences Inc., formerly known as OTR Acquisition Corp., is based in WOBURN, Mass.
Fiscal Year End Date: 12/31